Autobio Diagnostics Co., Ltd. engages in the research and development, production, and distribution of clinical diagnostic products. It develops immunoassay, biochemistry, microbiology, and IVD reagents; and instruments, such as automation and semi-automation systems, as well as medical laboratory solutions. The company's immunoassay products AutoLumo A2000 Plus, an automatic Chemiluminescence immunoassay analyzer; automatic microplate chemiluminescent enzyme immunoassay; and LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Its microbiology products comprise automated blood culture systems; blood culture bottles; AUTOMIC strips; and mycoplasma IES. The company was formerly known as Lifeclone Diagnostics Co., Ltd. and changed its name to Autobio Diagnostics Co., Ltd. in 2003. Autobio Diagnostics Co., Ltd. was founded in 1998 and is based in Zhengzhou, China. Autobio Diagnostics Co., Ltd. is a subsidiary of Zhengzhou Auto Industrial Co., Ltd.
Autobio Diagnostics Dividend Announcement
• Autobio Diagnostics announced a annually dividend of ¥1.05 per ordinary share which will be made payable on 2024-06-05. Ex dividend date: 2024-06-05
• Autobio Diagnostics annual dividend for 2024 was ¥1.05
• Autobio Diagnostics annual dividend for 2023 was ¥0.80
• Autobio Diagnostics's trailing twelve-month (TTM) dividend yield is 2.27%
• Autobio Diagnostics's payout ratio for the trailing twelve months (TTM) is 85.26%
• Autobio Diagnostics's dividend growth over the last five years (2018-2023) was 7.63% year
Autobio Diagnostics Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-06-05 | ¥1.05 | annually | 2024-06-05 |
2023-06-12 | ¥0.80 | annually | 2023-06-12 |
2022-06-20 | ¥0.72 | annually | 2022-06-20 |
2021-05-27 | ¥0.65 | annually | 2021-05-27 |
2020-06-11 | ¥0.69 | annually | 2020-06-11 |
2019-05-08 | ¥0.62 | annually | 2019-05-08 |
2018-05-08 | ¥0.55 | annually | 2018-05-08 |
2017-09-13 | ¥0.28 | annually | 2017-09-13 |
2017-04-13 | ¥0.50 | annually | 2017-04-13 |
Autobio Diagnostics Dividend per year
Autobio Diagnostics Dividend growth
Autobio Diagnostics Dividend Yield
Autobio Diagnostics current trailing twelve-month (TTM) dividend yield is 2.27%. Interested in purchasing Autobio Diagnostics stock? Use our calculator to estimate your expected dividend yield:
Autobio Diagnostics Financial Ratios
Autobio Diagnostics Dividend FAQ
Other factors to consider when evaluating Autobio Diagnostics as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Autobio Diagnostics stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Autobio Diagnostics's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Autobio Diagnostics publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Autobio Diagnostics distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Autobio Diagnostics are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Autobio Diagnostics sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Autobio Diagnostics distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Autobio Diagnostics declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Autobio Diagnostics's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Autobio Diagnostics's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.